Champions Oncology, Inc. (CSBR)
NASDAQ·Healthcare·Biotechnology
$5.90
-1.99%
Mkt Cap $81.23M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 12, 2026 | $16.61M | $16.56M | -0.33% | $0.09 | -$0.02 | -122.22% | — | — |
| Q4 2025 Dec 15, 2025 | $16.43M | $15.04M | -8.47% | $0.08 | $0.02 | -75.00% | — | — |
| Q3 2025 Sep 15, 2025 | $14.04M | $13.99M | -0.33% | $0.01 | -$0.03 | -400.00% | — | — |
| Q3 2025 Jul 23, 2025 | $14.67M | $12.36M | -15.76% | $0.06 | -$0.13 | -316.67% | — | — |
| Q1 2025 Mar 11, 2025 | $12.01M | $17.04M | +41.84% | -$0.01 | $0.31 | +3200.00% | — | — |
| Q4 2024 Dec 11, 2024 | $13.05M | $13.49M | +3.33% | $0.01 | $0.05 | +400.00% | — | — |
| Q3 2024 Sep 11, 2024 | $13.23M | $14.06M | +6.28% | $0.02 | $0.11 | +466.72% | — | — |
| Q3 2024 Jul 18, 2024 | $12.69M | $14.00M | +10.33% | -$0.16 | -$0.01 | +93.75% | — | — |
| Q1 2024 Mar 12, 2024 | $12.69M | $12.02M | -5.29% | -$0.06 | -$0.19 | -216.67% | — | — |
| Q4 2023 Dec 12, 2023 | $12.84M | $11.57M | -9.87% | -$0.17 | -$0.15 | +11.76% | — | — |
| Q3 2023 Sep 13, 2023 | $13.06M | $12.56M | -3.82% | -$0.10 | -$0.19 | -90.00% | — | — |
| Q3 2023 Jul 24, 2023 | $12.86M | $13.07M | +1.64% | -$0.12 | -$0.19 | -58.33% | — | — |
| Q1 2023 Mar 15, 2023 | $12.86M | $12.77M | -0.68% | -$0.06 | -$0.18 | -200.00% | — | — |
| Q4 2022 Dec 13, 2022 | $13.79M | $14.28M | +3.57% | -$0.00 | -$0.00 | -100.00% | — | — |
| Q3 2022 Sep 8, 2022 | $13.46M | $13.74M | +2.12% | -$0.01 | -$0.02 | -300.00% | — | — |
| Q3 2022 Jul 21, 2022 | $12.77M | $12.88M | +0.86% | -$0.01 | -$0.03 | -220.17% | — | — |
| Q1 2022 Mar 15, 2022 | $13.03M | $13.19M | +1.24% | $0.03 | $0.05 | +100.00% | — | — |
| Q4 2021 Dec 13, 2021 | $12.47M | $11.79M | -5.49% | $0.01 | $0.02 | +300.00% | — | — |
| Q3 2021 Sep 13, 2021 | $30.38M | $11.25M | -62.96% | -$0.00 | -$0.01 | -200.30% | — | — |
| Q3 2021 Jul 22, 2021 | $10.97M | $10.56M | -3.69% | $0.01 | -$0.04 | -500.00% | — | — |